Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Liebmann

Showing results (51-60 of 429) with videos related to

Pageof 43
Sort By:
Journal of Glaucoma|September 9, 2005
Central corneal thickness measurement in clinical practiceYevgeniy Shildkrot, Jeffrey M Liebmann, Bartosz Fabijanczyk, et al.
Retinal Cases & Brief Reports|April 25, 2025
Optic disc pit: A trigger for secondary multiple evanescent white dot syndromeShivesh Varma, Royce W S Chen, Jeffrey M Liebmann, et al.
Transactions of the American Ophthalmological Society|March 12, 2009
Noncontact in vivo confocal laser scanning microscopy of exfoliation syndromeZaher Sbeity, Pat-Michael Palmiero, Celso Tello, et al.
Ophthalmology|April 15, 2014
A new index to monitor central visual field progression in glaucomaCarlos Gustavo de Moraes, Rafael L Furlanetto, Robert Ritch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 19, 2020
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group StudyRobert M Feldman, George A Cioffi, Jeffrey M Liebmann, et al.
American Journal of Ophthalmology|January 25, 2011
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment StudyTheodore Krupin, Jeffrey M Liebmann, David S Greenfield, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
Comparison of PROGRESSOR and Glaucoma Progression Analysis 2 to Detect Visual Field Progression in Treated Glaucoma PatientsCarlos Gustavo De Moraes, Sara R Ghobraiel, Robert Ritch, et al.
JAMA Ophthalmology|January 10, 2016
Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With GlaucomaAlisa J Prager, Jeffrey M Liebmann, George A Cioffi, et al.
Scientific Reports|May 2, 2023
A potential primary endpoint for clinical trials in glaucoma neuroprotectionCarlos Gustavo De Moraes, Keith J Lane, Xiao Wang, et al.
JAMA Ophthalmology|November 5, 2020
Association of Patterns of Glaucomatous Macular Damage With Contrast Sensitivity and Facial Recognition in Patients With GlaucomaSitara H Hirji, Donald C Hood, Jeffrey M Liebmann, et al.
Pageof 43

Showing results (51-60 of 429) with videos related to

Sort By:
Pageof 43
Journal of Glaucoma|September 9, 2005
Central corneal thickness measurement in clinical practiceYevgeniy Shildkrot, Jeffrey M Liebmann, Bartosz Fabijanczyk, et al.
Retinal Cases & Brief Reports|April 25, 2025
Optic disc pit: A trigger for secondary multiple evanescent white dot syndromeShivesh Varma, Royce W S Chen, Jeffrey M Liebmann, et al.
Transactions of the American Ophthalmological Society|March 12, 2009
Noncontact in vivo confocal laser scanning microscopy of exfoliation syndromeZaher Sbeity, Pat-Michael Palmiero, Celso Tello, et al.
Ophthalmology|April 15, 2014
A new index to monitor central visual field progression in glaucomaCarlos Gustavo de Moraes, Rafael L Furlanetto, Robert Ritch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 19, 2020
Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group StudyRobert M Feldman, George A Cioffi, Jeffrey M Liebmann, et al.
American Journal of Ophthalmology|January 25, 2011
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment StudyTheodore Krupin, Jeffrey M Liebmann, David S Greenfield, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|June 25, 2015
Comparison of PROGRESSOR and Glaucoma Progression Analysis 2 to Detect Visual Field Progression in Treated Glaucoma PatientsCarlos Gustavo De Moraes, Sara R Ghobraiel, Robert Ritch, et al.
JAMA Ophthalmology|January 10, 2016
Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With GlaucomaAlisa J Prager, Jeffrey M Liebmann, George A Cioffi, et al.
Scientific Reports|May 2, 2023
A potential primary endpoint for clinical trials in glaucoma neuroprotectionCarlos Gustavo De Moraes, Keith J Lane, Xiao Wang, et al.
JAMA Ophthalmology|November 5, 2020
Association of Patterns of Glaucomatous Macular Damage With Contrast Sensitivity and Facial Recognition in Patients With GlaucomaSitara H Hirji, Donald C Hood, Jeffrey M Liebmann, et al.
Pageof 43